Logo image of SPNT

SIRIUSPOINT LTD (SPNT) Stock Fundamental Analysis

NYSE:SPNT - New York Stock Exchange, Inc. - BMG8192H1060 - Common Stock - Currency: USD

19.12  +0.04 (+0.21%)

Fundamental Rating

3

SPNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 145 industry peers in the Insurance industry. Both the profitability and financial health of SPNT have multiple concerns. SPNT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SPNT was profitable.
In the past year SPNT has reported a negative cash flow from operations.
SPNT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years SPNT had a positive operating cash flow.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

SPNT's Return On Assets of 1.20% is in line compared to the rest of the industry. SPNT outperforms 44.14% of its industry peers.
Looking at the Return On Equity, with a value of 7.25%, SPNT is doing worse than 64.83% of the companies in the same industry.
The Return On Invested Capital of SPNT (3.33%) is better than 70.34% of its industry peers.
Industry RankSector Rank
ROA 1.2%
ROE 7.25%
ROIC 3.33%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

SPNT's Profit Margin of 5.20% is in line compared to the rest of the industry. SPNT outperforms 41.38% of its industry peers.
SPNT's Profit Margin has declined in the last couple of years.
SPNT has a Operating Margin of 16.65%. This is in the better half of the industry: SPNT outperforms 72.41% of its industry peers.
SPNT's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.65%
PM (TTM) 5.2%
GM N/A
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SPNT is destroying value.
The number of shares outstanding for SPNT has been reduced compared to 1 year ago.
The number of shares outstanding for SPNT has been increased compared to 5 years ago.
The debt/assets ratio for SPNT has been reduced compared to a year ago.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

SPNT has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
SPNT has a Debt to Equity ratio of 0.33. This is comparable to the rest of the industry: SPNT outperforms 50.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.38
WACC8.86%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for SPNT have decreased strongly by -42.86% in the last year.
The earnings per share for SPNT have been decreasing by -14.97% on average. This is quite bad
Looking at the last year, SPNT shows a small growth in Revenue. The Revenue has grown by 3.02% in the last year.
Measured over the past years, SPNT shows a very strong growth in Revenue. The Revenue has been growing by 22.87% on average per year.
EPS 1Y (TTM)-42.86%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%0%
Revenue 1Y (TTM)3.02%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%-8.58%

3.2 Future

The Earnings Per Share is expected to grow by 44.67% on average over the next years. This is a very strong growth
Based on estimates for the next years, SPNT will show a small growth in Revenue. The Revenue will grow by 2.26% on average per year.
EPS Next Y127.41%
EPS Next 2Y58.74%
EPS Next 3Y44.67%
EPS Next 5YN/A
Revenue Next Year2.86%
Revenue Next 2Y5.48%
Revenue Next 3Y2.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

5

4. Valuation

4.1 Price/Earnings Ratio

SPNT is valuated rather expensively with a Price/Earnings ratio of 19.92.
Compared to the rest of the industry, the Price/Earnings ratio of SPNT indicates a slightly more expensive valuation: SPNT is more expensive than 64.83% of the companies listed in the same industry.
SPNT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.48.
With a Price/Forward Earnings ratio of 7.90, the valuation of SPNT can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SPNT indicates a somewhat cheap valuation: SPNT is cheaper than 68.97% of the companies listed in the same industry.
SPNT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.52.
Industry RankSector Rank
PE 19.92
Fwd PE 7.9
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

SPNT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SPNT is cheaper than 82.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.46
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SPNT's earnings are expected to grow with 44.67% in the coming years.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y58.74%
EPS Next 3Y44.67%

0

5. Dividend

5.1 Amount

No dividends for SPNT!.
Industry RankSector Rank
Dividend Yield N/A

SIRIUSPOINT LTD

NYSE:SPNT (7/18/2025, 10:02:10 AM)

19.12

+0.04 (+0.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-31 2025-07-31
Inst Owners88.44%
Inst Owner Change0%
Ins Owners2.12%
Ins Owner Change1.13%
Market Cap2.23B
Analysts84.44
Price Target20.4 (6.69%)
Short Float %2.14%
Short Ratio3.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP10.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.5%
Min EPS beat(2)-131.86%
Max EPS beat(2)108.87%
EPS beat(4)2
Avg EPS beat(4)-6.12%
Min EPS beat(4)-131.86%
Max EPS beat(4)108.87%
EPS beat(8)6
Avg EPS beat(8)50.93%
EPS beat(12)7
Avg EPS beat(12)14.93%
EPS beat(16)10
Avg EPS beat(16)14.42%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0.5%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.68%
EPS NY rev (3m)7.02%
Revenue NQ rev (1m)0.8%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)6.23%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.92
Fwd PE 7.9
P/S 0.79
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.18
EV/EBITDA 4.46
EPS(TTM)0.96
EY5.02%
EPS(NY)2.42
Fwd EY12.65%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS24.19
BVpS17.37
TBVpS16.19
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.2%
ROE 7.25%
ROCE 3.83%
ROIC 3.33%
ROICexc 3.54%
ROICexgc 4.96%
OM 16.65%
PM (TTM) 5.2%
GM N/A
FCFM N/A
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-10.36%
ROICexc growth 3YN/A
ROICexc growth 5Y-11.48%
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 1.38
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.86%
ROIC/WACC0.38
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%0%
EPS Next Y127.41%
EPS Next 2Y58.74%
EPS Next 3Y44.67%
EPS Next 5YN/A
Revenue 1Y (TTM)3.02%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%-8.58%
Revenue Next Year2.86%
Revenue Next 2Y5.48%
Revenue Next 3Y2.26%
Revenue Next 5YN/A
EBIT growth 1Y31.31%
EBIT growth 3YN/A
EBIT growth 5Y17.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.07%
FCF growth 3Y260.08%
FCF growth 5Y-11.94%
OCF growth 1Y-118.07%
OCF growth 3Y260.08%
OCF growth 5Y-11.94%